authors
-
Jerzy Świerż, Bronisław Stawarz, Andrzej Gomuła
- Z Kliniki Urologii Centralnego Szpitala Klinicznego WAM
Kierownik Kliniki: Prof. dr hab. med. B. Stawarz
summary
- Retrospective analysis of 87 patients with carcinoma of the testicle was conducted. We
- found that in 13% of patients first symptoms came from metastatic foci in abdominal lymph
- nodes and pulmonary metastases and were seemingly disconnected with carcionoma of the
- testicle. In 75% of patients the primary lesion was symptomless, detectable by ultrasonography
- examination. Neoplasm biochemie markers concentration increased with the neoplasm clinical
- progression degree. It is emphasised that in young males the oceurance of sound health
- non-typical abdominal pains, cough, dyspnoea or haenoptysis among other symptoms could
- suggest possibility of malignant carcinoma of the testicle
references
- I. Adamkiewicz K.: Złośliwe nowotwory jądra i ich leczenie. Urol. Pol., 1987, 40, 1. —
- 2.Bali D., Barrett A., Peckham M.: The management of metastatic semionoma testis. Cancer, 1982, 50, 2289. —
- 3. Clamon G., Henry K., Loening S.:Symptoms in patiens with germ cell neoplasms. Urologe, 1990, 36, 465. —
- 4. Collins P., Pugh R.: Classification and freąuency of testicular tumors. Br J. Urol., 1974, 36, 1. —
- 5. Fossa S., Borge L., Aass M.\\\\ The treatment of advanced metastatic seminoma. J. Clin. Oncol., 1987, 5, 1071. —
- 6. Hesketh P., Krane R.: Prognostic assessement in nonseminomatous testicular cancer. J. Urol., 1990, 144, 1. —
- 7. Jensen O., EsteveJ., Renard H.: Cancer in the Europen Community and its member states. Eur. J. Cancer., 1990, 11/12, 1167. —
- 8. Klepp O., Olsson A., Henrikson H.: Prognostic factors in nonseminomatous germ cell tumors of the testis. J. Clin. Onkol., 1990, 8, 509. —
- 9. Mackey E., Selers A.: A statistical review of malignant testicular tumors based on the expirience of the Ontario Cancer Foundation Clinics. Can. Med. Assoc. J., 1966, 94, 889. —
- 10. Madej G.: Skojarzone chemiczne i chirurgiczne, radykalne leczenie chorych na nienasieniaki. Nowotwory, 1984, 4, 306.
- II.Mann K.: Tumor markers in testicular carcinoma. Urologe, 1990, 36, 465. —
- 12. Mostofi F.: Histopatological typing of testis tumors. International histopatological elassyfication of tumors, WHO, Geneva, 1977. —
- 13. Patton J., Sietzman D., Zone R.: Diagnosis and treatment of testicular tumors. Am. J. Surg., 1970, 99, 525. —
- 14. Prise P., Hogan S., Horowich A.: The growth rate of metastatic nonseminomatous germ cell testicular tumours. Eur. J. Cancer, 1990, 26, 450.
- 15. Robson C, Bruce A., Charbonneau P.\\\\ Testicular tumors. J. Urol., 1965, 94, 440. —
- 16. Toner G., Geller N., Ten C:Serum tumor marker halflife during chemotherapy allows early predietion of complete response and survival in nonseminomatous germ cell tumors. Cancer Res., 1990, 50, 5904. —
- 17. Yehinsky T., Jaschke W., Vermund H.\\\\ Testicular tumors. An analysis of 112 consecutive cases Am. J. Roentgen., 1965, 95, 494. —
- 18. Zatoński W.: Nowotwory złośliwe w Polsce w 1989 roku. Biuletyn Instytutu Onkologii, 1992, 31.
correspondence
dr. med. Jerzy Swierż,
Klinika Urologii Centralnego Szpitala Klinicznego WAM.
00-909 Warszawa, ul. Szaserów 128,
|